|
PTPN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.79798406666032E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.57819987581343E-10 |
| Normal-vs-Stage2 |
1.363690E-04 |
| Normal-vs-Stage3 |
4.77950000021821E-07 |
| Normal-vs-Stage4 |
1.1709999969689E-08 |
| Stage1-vs-Stage2 |
8.615000E-01 |
| Stage1-vs-Stage3 |
7.606200E-01 |
| Stage1-vs-Stage4 |
5.428300E-02 |
| Stage2-vs-Stage3 |
7.356200E-01 |
| Stage2-vs-Stage4 |
1.177000E-01 |
| Stage3-vs-Stage4 |
1.526820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2243318298365E-12 |
| Normal-vs-AfricanAmerican |
1.442770E-03 |
| Normal-vs-Asian |
1.504500E-02 |
| Caucasian-vs-AfricanAmerican |
1.475170E-01 |
| Caucasian-vs-Asian |
8.290800E-01 |
| AfricanAmerican-vs-Asian |
7.087200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15081294388619E-13 |
| Normal-vs-Female |
6.77200000520628E-08 |
| Male-vs-Female |
7.438400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.466080E-02 |
| Normal-vs-Age(41-60Yrs) |
6.4011018707788E-12 |
| Normal-vs-Age(61-80Yrs) |
4.05560030003471E-10 |
| Normal-vs-Age(81-100Yrs) |
6.055500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.972200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.658000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.682000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.467400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.227200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.819000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.217310E-03 |
| Normal-vs-Grade 2 |
2.61449750738052E-11 |
| Normal-vs-Grade 3 |
1.71480000199509E-08 |
| Normal-vs-Grade 4 |
1.33300000038084E-07 |
| Grade 1-vs-Grade 2 |
7.625000E-01 |
| Grade 1-vs-Grade 3 |
8.169800E-01 |
| Grade 1-vs-Grade 4 |
2.656000E-01 |
| Grade 2-vs-Grade 3 |
1.270980E-01 |
| Grade 2-vs-Grade 4 |
2.231400E-01 |
| Grade 3-vs-Grade 4 |
4.119600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.12260003701937E-09 |
| Normal-vs-ccB subtype |
3.17159631890718E-11 |
| ccA subtype-vs-ccB subtype |
4.430400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.19000406487658E-11 |
| Normal-vs-N1 |
7.580100E-03 |
| N0-vs-N1 |
1.558830E-01 |
|
|
